Phone text program to help people with HIV in Uganda and Zambia stop smoking
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
This program uses tailored text messages and nicotine patches to help people living with HIV in Uganda and Zambia quit tobacco.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project ID | NIH-11418843 on NIH RePORTER |
What this research studies
If you join, you will be randomly assigned to receive either tailored SMS support, brief advice to quit, or nicotine patches while staying in HIV care at local clinics. The text messages are written to address challenges common for people with HIV such as depression, alcohol use, lack of awareness about smoking risks, and stigma. Researchers will follow up by phone and at the clinic to see whether you remain tobacco-free six months after starting. The goal is to find an affordable, clinic-deliverable way to help people with HIV stop using tobacco.
Who could benefit from this research
Good fit: Adults living with HIV who currently use tobacco and receive care at participating HIV clinics in Uganda or Zambia are the ideal candidates.
Not a fit: People who do not use tobacco, live outside Uganda or Zambia, or are not engaged in HIV care at participating clinics would not benefit from this program.
Why it matters
Potential benefit: If successful, the program could help people with HIV stop smoking and reduce tobacco-related illness and deaths in Uganda and Zambia.
How similar studies have performed: Phone-text and nicotine patch approaches have helped smokers in general populations, but this tailored SMS program for people living with HIV in sub-Saharan Africa is new and being tested in a randomized trial.
Where this research is happening
College Park, United States
- Univ of Maryland, College Park — College Park, United States (Active)
Researchers
- Principal investigator: Wipfli, Heather L — Univ of Maryland, College Park
- Study coordinator: Wipfli, Heather L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.